Compounds > mazindol

mazindol and raclopride

mazindol has been researched along with raclopride in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballard, C; Burn, D; Court, JA; Jaros, E; Johnson, M; Lloyd, S; Marshall, EF; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA; Thomas, N1
Araki, T; Imai, Y; Itoyama, Y; Matsubara, M; Mikami, T; Mizugaki, M; Tanji, H1
Bailey, A; Kitchen, I; McGee, T; Metaxas, A; Yoo, JH1
Arakawa, R; Ikeda, Y; Okubo, Y; Sakayori, T; Suzuki, H; Tateno, A1
Higuchi, M; Ikoma, Y; Ito, H; Kimura, Y; Maeda, J; Seki, C; Suhara, T; Takahata, K; Yamada, M; Yokokawa, K1

Other Studies

5 other study(ies) available for mazindol and raclopride

ArticleYear
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Brain : a journal of neurology, 1999, Volume: 122 ( Pt 8)

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Corpus Striatum; Dementia; Dopamine; Female; Homovanillic Acid; Humans; Lewy Bodies; Male; Mazindol; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Tetrahydronaphthalenes; Tritium

1999
Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2001, Volume: 12, Issue:3

    Topics: Animals; Benzazepines; Brain Chemistry; Dopamine Agents; Dopamine Uptake Inhibitors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Mazindol; Mice; Mice, Inbred C57BL; MPTP Poisoning; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase

2001
Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm.
    The European journal of neuroscience, 2008, Volume: 28, Issue:4

    Topics: Animals; Behavior, Animal; Cocaine; Dopamine Agonists; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Mazindol; Mice; Mice, Inbred C57BL; Motor Activity; Protein Binding; Quinolines; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance-Related Disorders

2008
Effect of mazindol on extracellular dopamine concentration in human brain measured by PET.
    Psychopharmacology, 2014, Volume: 231, Issue:11

    Topics: Adult; Appetite Depressants; Blood Chemical Analysis; Brain; Carbon Radioisotopes; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Space; Female; Humans; Male; Mazindol; Positron-Emission Tomography; Raclopride; Young Adult

2014
Measurement of psychological state changes at low dopamine transporter occupancy following a clinical dose of mazindol.
    Psychopharmacology, 2017, Volume: 234, Issue:3

    Topics: Brain; Carbon Radioisotopes; Consciousness; Corpus Striatum; Depersonalization; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Male; Mazindol; Positron-Emission Tomography; Raclopride; Young Adult

2017